[1]
Sikharulidze, I. et al. 2023. Antiplatelet Therapy for Secondary Prevention After Myocardial Infarction in Antiplatelet-Naive High Cardiovascular Risk Patients with Non-Obstructive Coronary Artery Disease. Georgian Biomedical and Medical Nexus. 1, 1 (Feb. 2023), 32–36. DOI:https://doi.org/10.52340/GBMN.2023.01.01.08.